Serum Institute says reports of Covid-19 Vaccine Covishield vaccine availability in 73 days false

COVISHIELD will be commercialised only after trials are proven successful and all the requisite regulatory approvals are in place.

Serum Institue of India (SII) issued a press release on August 23, clarifying that each one claims surrounding the supply of its COVID-19 vaccine,COVISHIELD, in 73 days are false.

"Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use," SII said during a statement they posted on Facebook, adding that COVISHIELD are going to be commercialised only after trials are proven successful and in any case the requisite regulatory approvals are in situ .

We would like to clarify that the current media claim on COVISHIELD's availability in 73 days is misleading.

Phase-3 trials are still underway. We will officially confirm it’s availability.

Read clarification statement here - https://t.co/FvgClzcnHr#SII #COVID19 #LatestNews pic.twitter.com/mQWrqgbzO4

— SerumInstituteIndia (@SerumInstIndia) August 23, 2020

The company also took to Twitter to line the record straight:

SII also touched on the Oxford-AstraZeneca vaccine. "The phase-3 trials for the Oxford-AstraZeneca vaccine are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially," the corporate said.

Also Read |

73 days to COVID-19 vaccine; Indians to get free shots

The cracks in the earth's magnetic field have increased, broken into two pieces are in danger, said NASA

https://latestnewsworld24x7.blogspot.com